Dr Manish Kumar Sharma Is Currently Practising As An Interventional Cardiologist At Dharma Vira Heart Centre, Sir Ganga Ram Hospital New Delhi. His Journey In Medical Science Began In 1995 When He Joined Mbbs At Llrm Medical College, Meerut. He Pursued Post Graduation (Md -Medicine) From Sn Medical College Agra (2002-2005). His Career In The Field Of Cardiology Started In 2008 When He Joined Sir Ganga Ram Hospital New Delhi. In 2019, Dr. Manish Joined Gripmer ( Ganga Ram Institute For Postgraduate Medical Education & Research) As An Associate Professor. Due To His Professional Achievement, He Was Awarded Mnams (2021) By National Academy Of Medical Sciences, New Delhi. He Is Expert In Complex Coronary Angioplasties Including Rotablation Under Guidance Of Intravascular Ultrasound (Ivus) And Optical Coherence Tomography (Oct). His Forte Is In Asd Device Closure, Balloon Valvuloplasty And Implantation Of Ppi, Aicd And Crt-D. He Is Also A Part Of Core Team Of Tavi (Transcatheter Aortic Valve Implantation). He Has Been A Part Of Many Landmark Trials Which Has Changed The Course Of Treatment In The Modern Medicine. He Has Also Published More Than Twenty Papers In Various National & International Journals.
Publications
1. Bhuwanesh Kandpal, Manish Kumar Sharma, Ashwani Mehta. Safety And Performance Of The Drug-Eluting Absorbable Metal Scaffold (Dreams) In Patients With De Novo Coronary Lesions: 12-Month Results Of The Prospective, Multicenter, First-In-Man Biosolve-I Trial. The Ganga Ram Journal Vol. 3, No.6, 2013: 287-288.
2. M. K. Sharma, S. C. Manchanda. Beta Blockers Should Not Be Used As First Line Antihypertensive Agent. Journal Of Clinical And Preventive Cardiology2013 (2),95-100
3. Manish Kumar Sharma, P.K. Chowbey, J.P.S.Sawhney. Effects Of Baritric Surgery On Cardiovascular Risk Factors. J.Preventive Cardiology 2015 Vol 5no1pg771-779.
4. Propofol To Relieve Radial Artery Spasm Monish Raut R.R. Mantri Manish Sharma Arun Maheshwari. Indian Heart Journal. 68 ( 2 0 1 6 ) 3 6 4 – 3 65. Https://Www.Ncbi.Nlm.Nih.Gov/Pmc/Articles/Pmc4911462/
5. Monish S. Raut, Arun Maheshwari, Manish Sharma, Sandeep Joshi, Arun Kumar, Akshay Gupta,Himanshu Goyal. Arterialization Of Central Venous Pressure Waveform. Annals Of Cardiac Anaesthesia 2016 , Vol 19(4)760-761. Https://Www.Proquest.Com/Openview/A7bda4c85450bee69d541a0348acd9b9/1?Pq-Origsite=Gscholar&Cbl=226527
6. Monish S. Raut, Sumir Dubey ,Arun Maheshwari ,Manish Sharma. Embolised Asd Device In Lv. Indian Heart Journal 68 (2016) 718–719. Https://Www.Ncbi.Nlm.Nih.Gov/Pmc/Articles/Pmc5079193/
7. Kumar A, Asaf Bb, Puri Hv, Sharma Mk, Lingaraju Vc, Rajput Vs. Video-Assisted Thoracoscopic Surgery Lobectomy: The First Indian Report J Minim Access Surg. 2018 Oct-Dec; 14(4): 291–297. Https://Www.Ncbi.Nlm.Nih.Gov/Pmc/Articles/Pmc6130190/
8. Deepak Agrawal, , S.C. Manchanda, J.P.S. Sawhney, , Bhuwanesh Kandpal, Rajneesh Jain, Ashwani Mehta, , Arun Mohanty, Rajiv Passey, Aman Makhija, Manish Kr. Sharma. To Study The Effect Of High Dose Atorvastatin 40 Mg Versus 80 Mg In Patients With Dyslipidemia. Indian Heart Journal, 2018, Volume 70, Pages S8-S12. Https://Doi.Org/10.1016/J.Ihj.2018.01.034
9. Jps Sawhney, Shashi Ranjan Prasad, Manish Sharma, Kushal Madan, A Mohanty , Rajiv Passey , Ashwani Mehta, B Kandpal , Aman Makhija , Rajneesh Jain , Rr Mantri , Bhola Shankar Vivek, Sc Manchanda , Ic Verma. Prevalence Of Familial Hypercholesterolemia In Premature Coronary Artery Disease Patients Admitted To A Tertiary Care Hospital In North India. Indian Heart Journal, 2019, Volume 71, Pages 118-122. Https://Doi.Org/10.1016/J.Ihj.2018.12.004
10. Molecular Studies In Familial Dilated Cardiomyopathy – A Pilot Study. Vyom Mori, J.P.S. Sawhney , I.C. Verma , Ashwani Mehta , Renu Saxena , Rajiv Passey , Arun Mohanty , Bhuwanesh Kandpal , B.S. Vivek , Manish Sharma , Ashish Kumar Jain , Dipak Katare. Ijc Heart & Vasculature, Volume 40, June 2022, 101023 Https://Doi.Org/10.1016/J.Ijcha.2022.101023
11. Manish Kumar Sharma, Jps Sawhney, Pk Chowbey, . Sc Manchanda, Pk Khanna, .S Dhawan, .Rr Mantri,.R Jain, R Passey,. A Mehta, B Kandpal, .A Mohanty, Bs Vivek, A Makhija. Effect Of Weight Loss (Achieved By Bariatric Surgery) On Various Cardiovascular Risk Factors (Glycemic Control, Lipid Profile, Crp And Homocysteine).. Indian Heart Journal 69(S2):S77 2009
12. Monish S.Raut Sumir Dubey Arun Maheshwari Manish Sharma. La Mass Shadow After Removal Of La Myxoma Indian Heart Journal2016 Volume 68, Supplement 2, Pages S178-S179. Https://Cyberleninka.Org/Article/N/625371.Pdf
13. Jayati Vohra, Kushal Madan, Manish Sharma, J.P.S Sawhney. Effect Of Exercise Training On Sleep Quality And Quality Of Life In Post Myocardial Infarction Patients.Circulation Research. 2016;119:A452 Https://Www.Ahajournals.Org/Doi/Abs/10.1161/Res.119.Suppl_1.452
14. K. Madan, J. Vohra, M. Sharma, J.P.S. Sawhney. Effect Of 4 Weeks Of Exercise Training On Cardiac Remodelling In Post Myocardial Infarction Patients. Global Heart 2016,Vol. 11, Issue 2, E142. Https://Doi.Org/10.1016/J.Gheart.2016.03.495
15. B.Shah, S.C.Manchanda, J P S Sawhney, A Makhija , M. Sharma, R Jain , R Passey, R.R.Mantri. Study Of Risk Factors And Assessment Of Thromboembolic And Bleeding Risk In Patients With Nonvalvular Atrial Fibrillation. Indian Heart Journal 69(S2):S96-S97 • November 2017
16. Neeraj Sharma, Rajat Mohan, Sangeeta Sachdeva, Payal Nindra, Arun Mohanty, Aman Makhija, B.S. Vivek, Manish Sharma. Evaluation Of Right Ventricular Function By Tissue Doppler Strain And Strain Rate Imaging In Different Grades Of Pulmonary Hypertension. Indian Heart Journal2017; 69(S2):S77.
17. J.P.S. Sawhney, K Tyagi, M.K. Sharma, K. Madan, J.K. Vanani, B Kandpal, A.Mehta. Lipoprotein (A) In Young Coronary Artery Disease And Its Association With Severity Of Coronary Artery Disease. Atherosclerosis 2021:331; E117. Https://Www.Atherosclerosis-Journal.Com/Article/S0021-9150(21)00618-3/Fulltext
18. J.P.S. Sawhney,V. Mori,M.K. Sharma,K. Madan,I.C. Verma. Coronary Risk Factors And Arcus Cornealis In Young Patients Of Coronary Artery Disease With And Without Familial Hypercholesterolemia. Atherosclerosis 2020; E213. Https://Www.Atherosclerosis-Journal.Com/Article/S0021-9150(20)31248-X/Fulltext
19. V Mori, Jps Sawhney, Mk Sharma, K Madan, B Khandpal, A Mohanty, R Passey, A Mehta. Prevalence Of Risk Factors In Young Coronary Artery Disease Patients Diagnosed With And Without Familial Hyperchoelsterolemia. Indian Heart Journal, 2019: 71 (Suppl 1), S 8
20. Aman Makhija, Manish Sharma. Book Chapter On “Diet For A Healthy Heart.” In: Jps Sawhney, Rajiv Passey, Atul Kakar, Samiran Nundy. Heart Attack. Elsevier. 2016. Pages: 37-39.
21. Manchanda Sc, Makhija A, Sharma Mk. History Of Statin. Textbook Of Cardiology., 2013 Jaypee Brother Medical Publisher Page 49-58.
22. Manchanda Sc, Sharma Mk . Book Chapter On Epidemology Of Heart Failure. Api Monograph On Heart Failure 2013.
23. Manchanda Sc,Sharmamk. Book Chapter On Prevention Of Heart Failure. Api Monograph On Heart Failure 2013
24. Jps Sawhney, Manish Kumar Sharma, Kushal Madan Book Chapter On."Exercise Training And Rehabilitation In Chronic Heart Failure". In : H.K. Chopra, Navin C. Nanda, Jagat Narula (Eds). Advances And Innovations In Heart Failure. Textbook Of Cardiology. Jaypee Brothers Medical Publishers (P) Ltd. 2019. Pages: 905-908.
25. Thesis: To Compare The Resolution Of St Segment Elevation At 90 And 180 Minutes After Starting The Streptokinase Infusion In Acute Myocardial Infarction Patients. (Md Medicine)
26. Thesis: Effect Of Weight Loss On Cardiovascular Risk Factors, Crp And Homocysteine In Obese Subjects Treated With Bariatric Surgery. (Dnb Cardiology).
27. Worked As A Co-Guide In The Thesis Named “Effect Of 4 Weeks Of Exercise Training On Cardiac Remodeling And Different Quality Of Life Parameters In Cad Patients”.
28. Worked As A Co-Guide In The Thesis Named “Prevalence Of Elevated Lipoprotein(A) In Patients With Heterozygous Familial Hypercholesterolemia”
29. Worked As A Co-Guide In The Thesis Named “High Intensity Statin With Or Without Ezetimibe To Achieve Low Density Lipid Cholesterol Goal In Patients With Acute Coronary Syndrome: A Randomized Controlled Study”
30. Worked As A Co-Guide In The Thesis Named “Correlation Of Elevated Lipoprotein (A) Levels With Severity Of Coronary Artery Disease”.
31. Worked As A Co-Guide In The Thesis Named “Lipid Lowering Effect Of High Intensity Statin In Stain Naïve Acute Coronary Syndrome Patients”.
32. Worked As A Co-Guide In The Predictive Ability Of Carotid Intima Media Thickness For Cardiovascular Events In Patients With Chronic Kidney Disease On Dialysis : A Prospective Observational Study”
33. A Phase 3, Randomized, Double-Blind. Double-Dummy. Parallel Group. Active Controlled Study To Evaluate The Efficacy And Safety Of Milvexian. An Oral Factor Xla Inhibitor. Versus Apixaban In Participants With Atrial Fibrillation, Principal Investigator
34. Real World, Prospective, Multi Center, Randomized Study To Assess Possible Benefits Of Engaging Patients Post Percutaneous Coronary Intervention(Pci) Through Whats App Based In Teractive Platform And Remote Nursing At Home For One Month (Emonitor), Principal Investigator
35. A Multi-Center, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study To Evaluate The Effect Of Amr101 On Cardiovascular Health And Mortality In Hypertriglyceridemic Patients With Cardiovascular Disease Or At High Risk For Cardiovascular Disease: Reduce-It (Reduction Of Cardiovascular Events With Epa-Intervention Trial)2018, Principal Investigator
36. “A Phase 3, Prospective, Multicenter, Double-Blind, Double-Dummy,Randomized, Active-Controlled, Parallel-Group, Group-Sequential, Adaptive, Event-Driven Study To Compare Efficacy, Safety, And Tolerability Of Macitentan 75 Mg Versus Macitentan 10 Mg In Patients With Pulmonary Arterial Hypertension Followed By An Open-Label Treatment Period With Macitentan 75mg”, Sub Investigator
37. Select - Semaglutide Effects On Cardiovascular Outcomes In People With Overweight Or Obesity, Sub Investigator
38. I8f-Mc-Gpgn (B) The Effect Of Tirzepatide Versus Dulaglutide On Major Adverse Cardiovascular Events In Patients With Type 2 Diabetes (Surpass-Cvot), Sub Investigator
39. Remit Hf A Prospective Multicenter Randomized Open Label Active Controlled Study To Assess Effect Of Remogliflozin On Biomarkers Of Heart Failure Compared To Empagliflozin In Patients Of Type 2 Diabetes Mellitus With Chronic Heart Failure, Sub Investigator
40. A Multinational, Randomized Open-Label, Parallel Group, Active-Controlled, Two-Arm, Long-Term Morbidity And Mortality Trial Involving Intensive Preventive Therapy (High Dose Renin-Angiotensin-Aldosterone System Inhibitors [Raasi], Beta-Blockade, Sodium-Glucose Co-Transporter 2 Inhibitors [Sglt2i]) Among Biomarker (N-Terminal Pro-B-Type Natriuretic Peptide, Nt-Probnp)-Identified High Risk Type 2 Dm Patients Without Pre-Existing Cardiovascular Disease", Sub Investigator
41. Ctqj230a12301 A Randomized Double-Blind, Placebo-Controlled, Multicenter Trial Assessing The Impact Of Lipoprotein (A)Lowering With Tqj230 On Major Cardiovascular Events In Patients With Established Cardiovascular Disease, Sub Investigator
42. Empact-Mi: A Streamlined, Multicenter, Randomized, Parallel Group, Double-Blind, Placebo Controlled, Superiority Trial To Evaluate The Effect Of Empagliflozin On Hospitalization For Heart Failure And Mortality In Patients With Acute Myocardial Infarction, Sub Investigator
43. Effect Of Semaglutide 2.4 Mg Once Weekly On Function And Symptoms In Subjects With Obesity Related Heart Failure With Preserved Ejection Fraction, And Type 2 Diabetes, Sub Investigator
44. Lib003-004, “Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study To Evaluate The Long-Term Efficacy And Safety Of Lib003 In Heterozygous Familial Hypercholesterolemia Patients On Stable Lipid-Lowering Therapy Requiring Additional Low-Density Lipoprotein Cholesterol Reduction (Liberate-Hefh)”, Sub Investigator
45. Effects Of Semaglutide On Functional Capacity In Patients With Type 2 Diabetes And Peripheral Arterial Disease (Stride), Sub Investigator
46. Protocol Title: Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study To Evaluate The Long-Term Efficacy And Safety Of Lib003 In Patients With Cardiovascular Disease On Stable Lipid-Lowering Therapy Requiring Additional Low-Density Lipoprotein Cholesterol Reduction (Liberate-Cvd), Sub Investigator
47. A Randomized, Double - Blind, Placebo - Controlled, Multicenter Trial Assesssing The Impact Of Inclisiran On Major Cardiovascular Events In Participants With Established Cardiovascular Disease (Victorion-2 Prevent), Sub Investigator
48. A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase Iiib Study Evaluating The Effect Of Inclisiran On Atherosclerotic Plaque Progression Assessed By Coronary Computed Tomography Angiography (Ccta) In Participants With A Diagnosis Of Non-Obstructive Coronary Artery Disease Without Previous Cardiovascular Events (Victorion-Plaque), Sub Investigator
49. Lib 003-007 Open-Label Extension Phase 3 Study To Evaluate The Long-Term Efficacy And Safety Of Lib003 In Patients With Homozygous And Heterozygous Familial Hypercholesterolemia, Cardiovascular Disease, Or At High Risk For Cardiovascular Disease, On Stable Lipid-Lowering Therapy Requiring Additional Low-Density Lipoprotein Cholesterol Reduction (Liberate-Ole), Sub Investigator
